Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy

Authors: Susan M. Domchek, Carol Aghajanian, Ronnie Shapira‐Frommer, Rita K. Schmutzler, M. William Audeh, Michael Friedländer, Judith Balmañà, Gillian Mitchell, Georgeta Fried, Salomon M. Stemmer, Ayala Hubert, Ora Rosengarten, Niklas Loman, Jane Robertson, Helen Mann, Bella Kaufman - Gynecologic Oncology 2015 cited by 300